| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/09/2002 | CN1330548A Phospholipid complexes of proanthocyanidin A2 used as antiatherosclerotic agents |
| 01/09/2002 | CN1330547A Pharmaceutical formulations |
| 01/09/2002 | CN1330546A Compositions comprising cefuroxime axetil |
| 01/09/2002 | CN1330543A Compositions and methods for amelioration of human female sexual dysfunction |
| 01/09/2002 | CN1330536A Biodegradable polymer encapsulated 5-hydroxytryptamine receptor antagonist and method for preparing the same |
| 01/09/2002 | CN1330532A Oil-in-water emulsion comprising micronised biologically active agent and appropriate emulsified system |
| 01/09/2002 | CN1330516A Improved of chewing gum containing medicament active agents release |
| 01/09/2002 | CN1329890A Dual-layer slow releasing tablet of benproperine phosphate |
| 01/09/2002 | CN1329886A Medical percutaneous preparation containing hydrophilic or salt form |
| 01/09/2002 | CN1077429C Preparation for epidermis and process for its preparation |
| 01/08/2002 | US6337324 Pharmaceutical combination |
| 01/08/2002 | US6337318 Drugs for peptide agonist |
| 01/08/2002 | US6337090 Orally administrable solid ribavirin dosage forms and process for making them |
| 01/08/2002 | US6337087 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
| 01/08/2002 | US6337086 Pressure sensitive adhesive compositions for transdermal drug delivery devices |
| 01/08/2002 | US6337083 Oral delivery method and composition for solid medications or dietary supplements |
| 01/08/2002 | US6337076 Applying onto hypertrophic scar a liquid formulation comprising collodion film-forming carrier having dermatologically effective amount of active ingredient capable of reducing size of scar or improving appearance |
| 01/08/2002 | US6337067 Water soluble dry compositions |
| 01/08/2002 | CA2344471C Hydrogen peroxide disinfectant with increased activity |
| 01/08/2002 | CA2193087C Topical compositions comprising n-acetyl-l-cysteine |
| 01/08/2002 | CA2165821C Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
| 01/08/2002 | CA2143263C Orally administrable raloxifene formulations |
| 01/08/2002 | CA2067228C Drug delivery system, method for preparing the same and use thereof |
| 01/08/2002 | CA2056357C Process for the preparation of a ligand-receptor complex |
| 01/08/2002 | CA2038744C Pharmaceutical composition containing slightly water-soluble drug |
| 01/03/2002 | WO2002000870A2 Method for transfecting cells using a magnetic field |
| 01/03/2002 | WO2002000844A2 Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use |
| 01/03/2002 | WO2002000839A2 Statement as to federally sponsored research |
| 01/03/2002 | WO2002000734A1 Dds compound and process for the preparation thereof |
| 01/03/2002 | WO2002000691A2 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | WO2002000685A1 Localized delivery to a target surface |
| 01/03/2002 | WO2002000269A1 The use of honey in wound dressings |
| 01/03/2002 | WO2002000268A1 Sprayable wound care compositions |
| 01/03/2002 | WO2002000265A1 Intramolecularly-quenched near infrared fluorescent probes |
| 01/03/2002 | WO2002000263A2 Tripeptide prodrug compounds |
| 01/03/2002 | WO2002000261A2 Surfactant-containing formulations for extended release of somatotropin |
| 01/03/2002 | WO2002000246A2 Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency |
| 01/03/2002 | WO2002000245A1 Neurotoxic oligomers |
| 01/03/2002 | WO2002000244A2 Protein mixtures for wound healing |
| 01/03/2002 | WO2002000243A2 Stabilized interleukin 2 |
| 01/03/2002 | WO2002000219A1 Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
| 01/03/2002 | WO2002000213A1 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
| 01/03/2002 | WO2002000212A1 Controlled release arginine formulations |
| 01/03/2002 | WO2002000210A2 Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease |
| 01/03/2002 | WO2002000207A1 The controlled release preparation of insulin and its method |
| 01/03/2002 | WO2002000205A1 Use of an acetylated pre-gelled starch with a high content of amylose |
| 01/03/2002 | WO2002000204A1 Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| 01/03/2002 | WO2002000203A1 Topical pharmaceutical formulations and methods of treatment |
| 01/03/2002 | WO2002000201A2 Method for preparing a composition |
| 01/03/2002 | WO2002000198A1 Process for preparing and harvesting crystalline particles |
| 01/03/2002 | WO2002000197A1 Method of making particles for use in a pharmaceutical composition |
| 01/03/2002 | WO2002000196A2 Wet milling process |
| 01/03/2002 | WO2002000195A2 Methods and compositions for treating pain of the mucous membrane |
| 01/03/2002 | WO2002000194A2 Polymeric micelle compositions |
| 01/03/2002 | WO2002000193A2 Multiple stimulus reversible hydrogels |
| 01/03/2002 | WO2002000173A2 Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cells |
| 01/03/2002 | WO2002000171A2 Composition for delivery of hematopoietic growth factor |
| 01/03/2002 | WO2002000170A2 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 01/03/2002 | WO2002000167A2 Modified forms of pharmacologically active agents and uses therefor |
| 01/03/2002 | WO2002000137A1 Biodegradable vehicles and delivery systems of biologically active substances |
| 01/03/2002 | WO2001071005A3 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 01/03/2002 | WO2001070275A3 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 01/03/2002 | WO2001070242A3 Compositions containing molecular iodine |
| 01/03/2002 | WO2001066601A8 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 01/03/2002 | WO2001064187A3 Anaesthetic formulations |
| 01/03/2002 | WO2001058472A3 Botulinum toxin pharmaceutical compositions |
| 01/03/2002 | WO2001053344A3 Chondromodulin-i related peptide |
| 01/03/2002 | WO2001049314A3 Glp-2 formulations |
| 01/03/2002 | WO2001049270A3 Odor-masking coating for a pharmaceutical preparation |
| 01/03/2002 | WO2001045695A3 Calcium formate for use as a phosphorus binder and a dietary supplement |
| 01/03/2002 | WO2001045676A3 Extended release oral dosage composition |
| 01/03/2002 | WO2001043749A3 Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
| 01/03/2002 | WO2001043748A3 Implant composition containing melengestrol acetate and trenbolone acetate |
| 01/03/2002 | WO2001043734A3 Transdermal administration of phenylpropanolamine |
| 01/03/2002 | WO2001041813A3 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 01/03/2002 | WO2001041800A3 Compositions and methods for stabilizing biological molecules upon lyophilization |
| 01/03/2002 | WO2001041737A3 Solid oral dosage form |
| 01/03/2002 | WO2001028587A3 Magnetic targeted carrier |
| 01/03/2002 | WO2001028527A3 Direct compression polymer tablet core |
| 01/03/2002 | WO2001024829A3 Binding agents |
| 01/03/2002 | US20020002250 Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof |
| 01/03/2002 | US20020002204 Blowing nitrogen gas through a hollow cylinder of an oxygen permeable plastic, molding the hollow cylinder into an oxygen permeable container, filling the container with aqueous albuterol or salt free of albuterol aldehyde and oxygen |
| 01/03/2002 | US20020002175 Nasal delivery of apomorphine in combination with glycol derivatives |
| 01/03/2002 | US20020002151 Minocycline-containing compositions |
| 01/03/2002 | US20020002148 Antibacterial aqueous ophthalmic formulations containing ofloxacin and use of chitosan for solubilizing ofloxacin suspended in an aqueous media |
| 01/03/2002 | US20020002147 Stabilizing amount of magnesium stearate; extended dosage formed by extrusion and spheronization and coated with a seal coating; nucleoside reverse transcriptase inhibitor; treatment of retroviruses, HIV |
| 01/03/2002 | US20020002133 Stabilized granulocyte colony stimulating factor |
| 01/03/2002 | US20020001631 Human growth hormone |
| 01/03/2002 | US20020001622 By blending redried corn starch, silica and at least one vitamin in a blender in any order to make a dry, free-flowing powder; economical method |
| 01/03/2002 | US20020001621 By using a variety of polymers, having varying starting molecular weights, by varying the hold time of the nucleophilic compound/polymer solution; encapsulated active agents |
| 01/03/2002 | US20020001619 Hydrophilic polymer, biologically active agent, and at least one precipitating agent, where biologically active agent is co-precipitated within the hydrophilic polymer |
| 01/03/2002 | US20020001617 Mixing a spray-dried particulate containing an active ingredient, a sublimable substance, a polyethylene glycol, and additive, tableting, and drying to sublime the sublimable substance until tablet becomes porous |
| 01/03/2002 | US20020001616 Novel method of treatment |
| 01/03/2002 | US20020001612 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| 01/03/2002 | US20020001610 Active ingredient delivery systems and devices based on porous matrices |
| 01/03/2002 | US20020001608 Biodegradable implant precursor |
| 01/03/2002 | US20020001602 Cosmetic/dermatologic cream; stability; nongreasy; composed primarily of water, for treating psoriasis; polyethersiloxane emulsifying agent |
| 01/03/2002 | US20020001600 Method of using lectins for prevention and treatment of skin diseases and disorders |
| 01/03/2002 | US20020001598 Pharmaceutical microspheres containing valproic acid for oral administration |
| 01/03/2002 | US20020001591 Compositions for the delivery of antigens |